Cleo Diagnostics Ltd
COV.AX
Australian Securities Exchange0.29
AUD
+0.00
- -
Total Valuation
Cleo Diagnostics Ltd carries a market capitalization of 41.29M, placing it among publicly traded companies globally.
| Market Cap | 41.29M |
| Enterprise Value | N/A |
Stock Price Statistics
Cleo Diagnostics Ltd's stock has declined approximately -21.62162% over the past 52 weeks. The 50-day moving average sits at 0.34, while the 200-day moving average is 0.52.
| Beta (5Y) | N/A |
| 52-Week Price Change | -21.62162% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.52 |
| Average Volume (20 Days) | N/A |